News
Centralised fund: pharma sector urges govt to let it utilise 1% of profit on in-house R&D activities
While the government is striving hard to boost exports to achieve sustainable economic growth, the pharmaceutical ...
Sri Lanka’s drive to boost local pharmaceutical manufacturing is running up against a critical bottleneck: the scarcity of ...
Guwahati: The College of Veterinary Science (CVSc) under Assam Agricultural University (AAU) in Khanapara has achieved a ...
The president’s proposed 25 percent tariffs on pharmaceutical imports will be catastrophic. There are other options to bring ...
The beauty industry is undergoing a significant transformation, driven by scientific advances, evolving consumer expectations ...
The UCPMP was introduced in March last year with an objective to bring about transparency and ensure ethical conduct in the ...
Sigachi Industries Ltd. (Sigachi), India's largest manufacturer of microcrystalline cellulose (MCC), has demonstrated robust ...
The total market size of the Indian Pharma Industry is expected to reach US$ 130 billion by 2030 and US$ 450 billion market by 2047. * Indian pharmaceutical companies are projected to achieve a ...
R Mukundan, MD and CEO of Tata Chemicals, has taken over as the President-Designate for the upcoming term. Suchitra K Ella, ...
EY's Rajiv Memani takes charge as CII President for 2025-26, succeeding Sanjiv Puri. R Mukundan is President-Designate and ...
This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine ...
The newly constituted national council of Confederation of Indian Industry (CII) at a meeting elected its new office bearers for the year 2025-26. Rajiv Memani, Chairman and CEO of EY India has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results